| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 8,626 | $24.06 | $207,574.87 | -4.2% | -18.0% | -86.1% | |
| Feb 16, 2023 | PETV Petvivo Holdings, Inc. | Martin James Rudolph | Director | Buy | 103 | $2.99 | $307.97 | - | - | - | |
| Feb 16, 2023 | IDXX Idexx Laboratories Inc /de | Junius Daniel M | Director | Sell | 2,187 | $511.68 | $1,119,043.50 | -42.3% | -3.8% | +9.7% | |
| Feb 16, 2023 | IDXX Idexx Laboratories Inc /de | Turner Kathy V62 | Senior Vice President | Sell | 1,010 | $510.09 | $515,186.95 | -6.4% | -3.8% | +9.7% | |
| Feb 16, 2023 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 20,000 | $10.25 | $204,976.86 | -2.3% | -28.7% | -28.5% | |
| Feb 16, 2023 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 1,124 | $240.77 | $270,625.48 | -77.5% | +28.3% | +57.7% | |
| Feb 16, 2023 | ISRG Intuitive Surgical Inc | Desantis Robert49 | EVP &Chief Product Officer | Sell | 1,971 | $240.77 | $474,557.67 | -23.6% | +28.3% | +57.7% | |
| Feb 16, 2023 | HYPR Hyperfine, Inc. | Gupta Alok | Chief Financial Officer | Sell | 5,613 | $1.39 | $7,802.07 | -4.8% | -3.7% | -17.2% | |
| Feb 16, 2023 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, GC, CCO And Cs | Sell | 23,018 | $5.90 | $135,916.64 | -2.8% | -53.2% | -47.5% | |
| Feb 16, 2023 | HYPR Hyperfine, Inc. | Siddiqui Khan54 | CMO And Chief Strategy Officer | Sell | 4,635 | $1.39 | $6,442.65 | -5.4% | -3.7% | -17.2% | |
| Feb 15, 2023 | PETV Petvivo Holdings, Inc. | Martin James Rudolph | Director | Buy | 8,400 | $2.65 | $22,291.00 | +2.4% | - | - | |
| Feb 15, 2023 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 5,675 | $214.83 | $1,219,143.79 | -1.3% | +6.4% | -15.0% | |
| Feb 15, 2023 | EMBC Embecta Corp. | Melcher David F | Director | Buy | 3,100 | $32.51 | $100,781.00 | +16.9% | -12.0% | -54.9% | |
| Feb 15, 2023 | TMCI Treace Medical Concepts, Inc. | Scanlan Sean F.65 | Chief Innovation Officer | Sell | 25,000 | $21.69 | $542,235.00 | -71.5% | +17.5% | -27.9% | |
| Feb 15, 2023 | BSX Boston Scientific Corp | Brennan Daniel J.47 | EVP And CFO | Sell | 7,572 | $47.14 | $356,927.42 | -2.7% | +13.7% | +39.8% | |
| Feb 15, 2023 | MOVE Movano Inc. | Caballero Ruben | Director | Buy | 18,200 | $1.41 | $25,662.00 | +45.5% | -30.9% | -54.3% | |
| Feb 15, 2023 | TMCI Treace Medical Concepts, Inc. | Timbie Thomas E69 | Director | Sell | 50,000 | $21.71 | $1,085,350.00 | -4.0% | +17.5% | -27.9% | |
| Feb 15, 2023 | RMD Resmed Inc | Douglas Robert Andrew71 | President And COO | Sell | 1,500 | $213.50 | $320,250.00 | -0.6% | +6.4% | -15.0% | |
| Feb 15, 2023 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Tmtt | Sell | 4,000 | $76.01 | $304,040.00 | -17.5% | +13.8% | +10.4% | |
| Feb 15, 2023 | STIM Neuronetics, Inc. | Furlong Stephen74 | CFO | Sell | 25,551 | $5.74 | $146,781.94 | -2.8% | -54.5% | -46.8% | |
| Feb 15, 2023 | INSP Inspire Medical Systems, Inc. | Herbert Timothy P.71 | CEO And President | Sell | 31,853 | $275.39 | $8,772,093.57 | -28.8% | +7.4% | -30.7% | |
| Feb 14, 2023 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 2,173 | $70.08 | $152,283.84 | -0.6% | +10.3% | +31.7% | |
| Feb 14, 2023 | IDXX Idexx Laboratories Inc /de | Turner Kathy V62 | Senior Vice President | Sell | 2,000 | $504.59 | $1,009,188.88 | -6.0% | -2.7% | +11.3% | |
| Feb 14, 2023 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 4,070 | $70.15 | $285,510.50 | -75.8% | +10.3% | +31.7% | |
| Feb 14, 2023 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Chairman &CEO | Sell | 19,875 | $77.00 | $1,530,308.25 | -5.5% | +16.1% | +12.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.